| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 06/10/1998 | EP0714403B1 Aqueous multiple-phase isolation of polypeptide |
| 06/10/1998 | EP0500699B1 Cross-protective salmonella vaccines |
| 06/10/1998 | CN1184507A Endo beta-1, 4 -glucanase from aspergillus |
| 06/10/1998 | CN1184506A DNA molecule relating to suppression of gene expression and novel protein |
| 06/10/1998 | CN1184159A Improved fermentative carotenoid production |
| 06/10/1998 | CN1184157A Method for producing nucleoside-5' -phosphate ester |
| 06/10/1998 | CN1184156A Phytase and the clone and expression of its gene |
| 06/10/1998 | CN1184155A High-efficiency mycoplasma culture medium and its preparation |
| 06/10/1998 | CN1184154A Cultivation of paecilomyces species, using silkworms |
| 06/10/1998 | CN1038693C Process for fermentative preparation of amino acids |
| 06/10/1998 | CN1038691C Stabilized lyophilized mammlian cells and method of making same |
| 06/10/1998 | CN1038637C Method for cultivating edible mushroom by raising fungus grass culturing material nutrient |
| 06/09/1998 | USRE35823 Proteins useful in the regulation of κB-containing genes |
| 06/09/1998 | US5763589 Human membrane protein |
| 06/09/1998 | US5763572 HTLV-II peptide antigens |
| 06/09/1998 | US5763571 Amino acid sequences which inhibit binding |
| 06/09/1998 | US5763397 Glycopeptides, a process for their preparation and their use |
| 06/09/1998 | US5763385 Genetic engineered culture product; stability, heat resistane, oxidation resistance |
| 06/09/1998 | US5763271 Vasodilatory and immune suppressant peptides |
| 06/09/1998 | US5763267 Apparatus for the large scale growth and packaging of cell suspensions and three-dimensional tissue cultures |
| 06/09/1998 | US5763260 Method to alter the properties of acetylated xylan |
| 06/09/1998 | US5763256 Subtilisin-type serine protease having catalytic serine at or near amino terminus replaced by or converted to cysteine, specified proline replaced with different helix-forming amino acid |
| 06/09/1998 | US5763254 Enzyme capable of degrading cellulose or hemicellulose |
| 06/09/1998 | US5763253 Methods of preparing tissue plasiminogen activator derivative composition |
| 06/09/1998 | US5763251 Viral products |
| 06/09/1998 | US5763250 Chimeric toxins |
| 06/09/1998 | US5763247 Nucleotide fragments and uses thereof for obtaining bactericide-producing compositions |
| 06/09/1998 | US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus |
| 06/09/1998 | US5763241 Insect resistant plants |
| 06/09/1998 | US5763236 Method for producing ketone or aldehyde using an alcohol dehydrogenase of Candida Parapsilosis |
| 06/09/1998 | US5763221 Obtained by transforming hyphomycetes by plasmid constructed with promoter, terminator, marker gene and target aspergillus niger alpha-amylase gene |
| 06/09/1998 | US5763220 Human apoptosis-related calcium-binding protein |
| 06/09/1998 | US5763214 Fibroblast growth factor 11 |
| 06/09/1998 | US5763212 Binding low molecular mass cell penetrating ligand to protein |
| 06/09/1998 | US5763211 Polynucleotide which encodes receptor polypeptide |
| 06/09/1998 | US5763210 Recombinant production of interferon-gamma binding proteins |
| 06/09/1998 | US5763195 Method and compositions for making ACSF and ACSF antagonists |
| 06/09/1998 | US5763194 Loading sample into device having semipermeable membrane provided with ligand reactive with desired cell type, incubating to allow deposition and binding of desired cell type to ligand |
| 06/09/1998 | US5762941 Modified shigella having reduced pathogenicity |
| 06/09/1998 | US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 06/04/1998 | WO1998023774A1 Fen-1 endonucleases, mixtures and cleavage methods |
| 06/04/1998 | WO1998023765A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent |
| 06/04/1998 | WO1998023763A1 Heterologous antigens in live cell v. cholerae strains |
| 06/04/1998 | WO1998023762A2 Methods of producing a recombinant protein |
| 06/04/1998 | WO1998023761A1 HUMANIZED ANTI-CD11a ANTIBODIES |
| 06/04/1998 | WO1998023754A1 Process for the expression of genes of the dengue viruses |
| 06/04/1998 | WO1998023752A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses |
| 06/04/1998 | WO1998023751A1 Processed polypeptides with il-16 activity, processes for their production and their use |
| 06/04/1998 | WO1998023750A2 Mammalian chemokines |
| 06/04/1998 | WO1998023749A1 Fibroblast growth factor-13 |
| 06/04/1998 | WO1998023747A2 Isolated mammalian dendritic cell genes; related reagents |
| 06/04/1998 | WO1998023741A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 06/04/1998 | WO1998023740A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis |
| 06/04/1998 | WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/04/1998 | WO1998023727A1 Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof |
| 06/04/1998 | WO1998023726A1 Culture medium and method for repair of microbial cells |
| 06/04/1998 | WO1998023725A1 Methods and apparatus for enhancement of mass transfer of a fluid in a porous matrix system containing biomass |
| 06/04/1998 | WO1998023647A1 Polysaccharide derivatives and hydraulic compositions |
| 06/04/1998 | WO1998023641A1 Dna encoding lepidopteran-active delta-endotoxins and its use |
| 06/04/1998 | WO1998023631A1 Novel bacterial polypeptides and polynucleotides |
| 06/04/1998 | WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 06/04/1998 | DE19740319A1 Verfahren und Anordnung zur beschleunigten Hefevermehrung im Brauprozeß Method and apparatus for yeast growth accelerated in the brewing process |
| 06/04/1998 | DE19649233A1 Nucleic acid encoding interleukin-16 polypeptide |
| 06/04/1998 | CA2274313A1 Mammalian chemokines |
| 06/04/1998 | CA2272988A1 Methods of producing a recombinant protein |
| 06/04/1998 | CA2272847A1 Dna encoding lepidopteran-active delta-endotoxins and its use |
| 06/04/1998 | CA2272846A1 Processed polypeptides with il-16 activity, processes for their production and their use |
| 06/04/1998 | CA2272637A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent |
| 06/04/1998 | CA2272345A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis |
| 06/04/1998 | CA2272239A1 Fibroblast growth factor-13 |
| 06/03/1998 | EP0845536A2 Protein having ethylenediamine-N,N'-disuccinic acid: ethylenediamine lyase activity and gene encoding the same |
| 06/03/1998 | EP0845535A2 Leader peptidase (lep) from Streptococcus |
| 06/03/1998 | EP0845534A2 Esterase gene and its use |
| 06/03/1998 | EP0845532A2 Enzymes for the synthesis of coniferyl alcohol, coniferyl aldehyde, ferulic acid, vanillin, vanillic acid and their applications |
| 06/03/1998 | EP0845529A2 Human G-protein coupled receptor protein cloned form fetal brain CDNA library |
| 06/03/1998 | EP0845043A1 Transport proteins and their uses |
| 06/03/1998 | EP0845038A1 Deuteriated substances |
| 06/03/1998 | EP0845032A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof |
| 06/03/1998 | EP0845030A1 Novel glycerol phosphatase with stereo-specific activity |
| 06/03/1998 | EP0845004A1 Epitope tagging system |
| 06/03/1998 | EP0844885A2 Chemical compounds |
| 06/03/1998 | EP0580621B1 Nucleic acid fragment of the x chromosome region involved in the fragile x syndrome, nucleotide probe and method of diagnosing mental retardation with fragile x |
| 06/03/1998 | EP0358692B1 Cholera vaccines |
| 06/03/1998 | CN1183810A Subtilisin DY variants having decreased adsorption and increased hydrolysis |
| 06/03/1998 | CN1183808A Gene for enzyme having both alkaline pullulanase and alkaline alpha-amylase activities |
| 06/03/1998 | CN1183807A Human chemokine beta-13 |
| 06/03/1998 | CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies |
| 06/03/1998 | CN1183800A Protease variants and compositions |
| 06/03/1998 | CN1183473A Breeding of high-yield strain for pectase by semiconductor laser irradiation |
| 06/03/1998 | CN1183472A Novel alcohol aldehyde dehydrogenases |
| 06/02/1998 | US5760180 Kits and dna(cdna) codes and cloning expression vectors |
| 06/02/1998 | US5759994 Antithrombin peptide for cardiovascular disorders |
| 06/02/1998 | US5759852 Expression vector containing PL6M promoter and TAT32 ribosome binding site and host cells transformed therewith |
| 06/02/1998 | US5759845 Secretion of clostridium cellulase by E. coli |
| 06/02/1998 | US5759831 Obtained from streptomyces |
| 06/02/1998 | US5759828 Cyclic di-guanylate metabolic enzymes |
| 06/02/1998 | US5759824 Genes for butyrobetaine/crotonobetaine-l-carnitine metabolism and their use for the microbiological production of l-carnitine |
| 06/02/1998 | US5759823 Mixing in aqueous medium activated donor monosaccharide with acceptor saccharide in presence of glycosyltransferase, maintaining to glycosylate acceptor saccharide |
| 06/02/1998 | US5759818 N-terminal CTP extended pharmaceutical peptides and proteins |
| 06/02/1998 | US5759816 Bovine growth hormone with restriction mapping and plasmids |